Nuo Therapeutics Inc (AURX) - Medical Equipment - Deals and Alliances Profile

Nuo Therapeutics Inc (AURX) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME81703D
  • |
  • Pages: 28
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company's flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient's innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has its facilities in Nashville, Tennessee; and Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (AURX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Nuo Therapeutics Inc, Medical Equipment, Deal Details 10

Venture Financing 10

Aldagen Raises Additional USD 0.06 Million In Venture Financing 10

Partnerships 11

Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11

Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12

Nuo Therapeutics Amends Licensing Agreement with Arthrex 13

Equity Offering 14

Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14

Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16

Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17

Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18

Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19

Cytomedix Completes Private Placement Of Shares For USD 7 Million 20

Cytomedix Files Registration Statement For Public Offering Of Securities For Up To USD 35 Million 21

Acquisition 22

Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22

Nuo Therapeutics Inc-Key Competitors 24

Nuo Therapeutics Inc-Key Employees 25

Nuo Therapeutics Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Legal and Regulatory 27

Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28

List of Figures

Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Nuo Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Nuo Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

Nuo Therapeutics Inc, Medical Equipment, Key Facts, 2017 2

Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Nuo Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8

Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Aldagen Raises Additional USD 0.06 Million In Venture Financing 10

Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11

Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12

Nuo Therapeutics Amends Licensing Agreement with Arthrex 13

Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14

Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16

Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17

Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18

Nuo Therapeutics Raises USD5 Million n Private Placement of Shares and Warrants 19

Cytomedix Completes Private Placement Of Shares For USD 7 Million 20

Cytomedix Files Registration Statement For Public Offering Of Securities For Up To USD 35 Million 21

Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22

Nuo Therapeutics Inc, Key Competitors 24

Nuo Therapeutics Inc, Key Employees 25

Nuo Therapeutics Inc, Other Locations 26

Nuo Therapeutics Inc, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Nuo Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17980
Site License
USD 500 INR 35960
Corporate User License
USD 750 INR 53940

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com